These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 9196603

  • 1. The relationship between overnight GH levels and insulin concentrations in adolescents with insulin-dependent diabetes mellitus (IDDM) and the impact of recombinant human insulin-like growth factor I (rhIGF-I).
    Cheetham TD, Connors M, Clayton K, Watts A, Dunger DB.
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):415-24. PubMed ID: 9196603
    [Abstract] [Full Text] [Related]

  • 2. The effects of recombinant human insulin-like growth factor I on growth hormone secretion in adolescents with insulin dependent diabetes mellitus.
    Cheetham TD, Clayton KL, Taylor AM, Holly J, Matthews DR, Dunger DB.
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):515-22. PubMed ID: 8187319
    [Abstract] [Full Text] [Related]

  • 3. Recombinant human insulin-like growth factor-I abolishes changes in insulin requirements consequent upon growth hormone pulsatility in young adults with type I diabetes mellitus.
    Crowne EC, Samra JS, Cheetham T, Watts A, Holly JM, Dunger DB.
    Metabolism; 1998 Jan; 47(1):31-8. PubMed ID: 9440474
    [Abstract] [Full Text] [Related]

  • 4. Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus.
    Acerini CL, Harris DA, Matyka KA, Watts AP, Umpleby AM, Russell-Jones DL, Dunger DB.
    Metabolism; 1998 Dec; 47(12):1481-9. PubMed ID: 9867078
    [Abstract] [Full Text] [Related]

  • 5. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1.
    Cotterill AM, Daly F, Holly JM, Hughes SC, Camacho-Hübner C, Abdulla AF, Gale EA, Savage MO.
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):567-74. PubMed ID: 8548941
    [Abstract] [Full Text] [Related]

  • 6. The effects of recombinant human IGF-I administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-I, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitus.
    Cheetham TD, Holly JM, Baxter RC, Meadows K, Jones J, Taylor AM, Dunger DB.
    J Endocrinol; 1998 Apr; 157(1):81-7. PubMed ID: 9614361
    [Abstract] [Full Text] [Related]

  • 7. rhIGF-I administration reduces insulin requirements, decreases growth hormone secretion, and improves the lipid profile in adults with IDDM.
    Carroll PV, Umpleby M, Ward GS, Imuere S, Alexander E, Dunger D, Sönksen PH, Russell-Jones DL.
    Diabetes; 1997 Sep; 46(9):1453-8. PubMed ID: 9287046
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment.
    Carroll PV, Umpleby M, Alexander EL, Egel VA, Callison KV, Sönksen PH, Russell-Jones DL.
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):739-46. PubMed ID: 10209561
    [Abstract] [Full Text] [Related]

  • 9. Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system.
    Thrailkill K, Quattrin T, Baker L, Litton J, Dwigun K, Rearson M, Poppenheimer M, Kotlovker D, Giltinan D, Gesundheit N, Martha P.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1181-7. PubMed ID: 9100593
    [Abstract] [Full Text] [Related]

  • 10. Recombinant IGF-I therapy in insulin-dependent diabetes mellitus.
    Savage MO, Dunger DB.
    Diabetes Metab; 1996 Jul; 22(4):257-60. PubMed ID: 8767172
    [Abstract] [Full Text] [Related]

  • 11. Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes.
    Saukkonen T, Amin R, Williams RM, Fox C, Yuen KC, White MA, Umpleby AM, Acerini CL, Dunger DB.
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4634-41. PubMed ID: 15356074
    [Abstract] [Full Text] [Related]

  • 12. Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus.
    Acerini CL, Patton CM, Savage MO, Kernell A, Westphal O, Dunger DB.
    Lancet; 1997 Oct 25; 350(9086):1199-204. PubMed ID: 9652560
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impact of increased growth hormone secretion on carbohydrate metabolism in adolescents with diabetes.
    Dunger DB, Edge JA, Pal R, Taylor AM, Holly JM, Matthews DR.
    Acta Paediatr Scand Suppl; 1991 Oct 25; 377():69-77; discussion 78. PubMed ID: 1723835
    [Abstract] [Full Text] [Related]

  • 16. Spontaneous and stimulated growth hormone release in adolescents with type I diabetes mellitus: effects of metabolic control.
    Miller JD, Wright NM, Lester SE, Felsing NE, Linzer J, Chan E, White DA, Charles MA.
    J Clin Endocrinol Metab; 1992 Oct 25; 75(4):1087-91. PubMed ID: 1400876
    [Abstract] [Full Text] [Related]

  • 17. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
    Camacho-Hübner C, Woods KA, Miraki-Moud F, Hindmarsh PC, Clark AJ, Hansson Y, Johnston A, Baxter RC, Savage MO.
    J Clin Endocrinol Metab; 1999 May 25; 84(5):1611-6. PubMed ID: 10323388
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The role of IGF-binding proteins in mediating the effects of recombinant human IGF-I on insulin requirements in type 1 diabetes mellitus.
    Crowne EC, Samra JS, Cheetham T, Acerini CL, Watts A, Holly JM, Dunger DB.
    J Clin Endocrinol Metab; 2001 Aug 25; 86(8):3686-91. PubMed ID: 11502796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.